Microdosing Cannabis Edibles for Alzheimer's

Alzheimer’s disease progressively steals away memory and cognitive function. Some people are turning to microdoses of cannabis in an attempt to slow the disease and relieve symptoms of Alzheimer’s.

This is where our low-dose edibles shine: microdoses could improve mood, sleep, appetite, and mental health—without the impairment associated with chronic high-dose cannabis use. 

Our edibles are the safest way to consume THC, CBD, and other cannabis compounds, allowing you to fully enjoy the benefits of microdosing THC. 

We’ve already explored the beneficial effects THC microdoses have on dementia. Find out how our low-dose fruit-filled gummies may deliver measurable benefits to Alzheimer’s patients.

What Is Alzheimer’s Disease?

Alzheimer's disease is a progressive neurodegenerative disorder that impairs memory, thinking, and behavior. As it advances, Alzheimer's destroys brain cells and shrinks different areas of the brain involved in cognitive functioning like memory, judgment, and language. 

The disease starts slowly, with mild memory loss and confusion. Over time, symptoms worsen and become severe enough to interfere with daily tasks and independent living. 

While the exact causes are still not fully understood, Alzheimer's is characterized by the buildup of abnormal protein deposits in the brain. 

Alzheimer's is the most common cause of dementia, accounting for 60-80% of cases. Currently, there is no cure, but treatments are available to temporarily improve or slow symptoms. Alzheimer’s affects over 6 million Americans and is the 6th leading cause of death in the United States.

What Causes Alzheimer’s Disease?

Alzheimer’s occurs when abnormal protein deposits called amyloid plaques and tau tangles build up in the brain. Amyloid plaques are sticky protein fragments that build up between neurons and disrupt cell function. Tau tangle proteins are another hallmark of brain change seen in Alzheimer’s: abnormal tau proteins twist into tangles inside nerve cells, blocking nutrient transport and collapsing neurons. 

These abnormal behaviors of brain proteins negatively affect cognitive functions, eventually leading to brain cell death. 

Genetics, age, and lifestyle also influence the development of Alzheimer’s. Certain genes, like APOE e4, increase the risk of Alzheimer's, but that’s not a guarantee you will get the disease. However, having a first-degree relative with Alzheimer’s is a much higher risk factor. 

Advancing age is the greatest risk factor, with incidence doubling every 5 years after 65. Before the age of 65, Alzheimer's is considered rare.

Other things can also cause Alzheimer’s, such as:

• Moderate to severe brain injuries increase risk of developing Alzheimer's later in life.
• Vascular factors like heart disease, stroke, high blood pressure, diabetes, and high cholesterol are all linked to increased Alzheimer's risk, likely due to blood vessel damage in the brain.
• Lifestyle can have a significant impact on your chances of developing Alzheimer’s. Smoking, obesity, unhealthy diet, depression, and cognitive inactivity are associated with increased Alzheimer's risk. 
• all individuals with Down syndrome develop Alzheimer's pathology after 40 due to an extra chromosome 21 gene.

The exact causes of Alzheimer’s remain unclear, though most experts believe it involves a complex interaction between all of these factors that affect the brain over time.

What are the Symptoms of Alzheimer’s Disease?

The symptoms and progression of Alzheimer's align closely with those of other dementias, though the underlying brain changes are unique to each condition. While Alzheimer's follows a distinct pattern of amyloid and tau brain abnormalities, other dementias have different pathological features. But all dementias involve progressive cognitive and functional decline.

In the early stages of Alzheimer's disease, symptoms are often subtle and develop gradually. The first signs are typically difficulties with short-term memory and learning new information. Patients may struggle to recall recent conversations, events, or names, while long-term memories remain intact. Complex tasks like managing finances, cooking, or driving also become increasingly challenging.

As Alzheimer's progresses to moderate stages, symptoms become more pronounced and begin interfering with daily life:

• Memory loss worsens, while gaps in recollection expand. Patients may repeat questions or conversations, misplace possessions, forget relationships, and get lost in familiar places.
• Thinking and judgment decline. Planning and problem solving become more difficult. Patients may have trouble following instructions.
• Behavior changes like apathy, anxiety, irritability, and depression emerge. Some patients experience paranoia or delusions. 
• Speaking and writing abilities deteriorate. Patients struggle to find the right words, repeat phrases, or speak fluently. Reading comprehension declines.
• Visual and spatial processing problems arise, affecting coordination, driving ability, and object recognition. Patients may also experience hallucinations.

In late stage Alzheimer's, memory and cognitive function are severely impaired. Severe memory loss leaves patients disoriented about time and place. They cannot recognize relatives or recall major life events. Speech ability is lost, and mutism sets in. Patients lose their ability to walk without assistance. They become completely dependent on caregivers for activities like eating, bathing, dressing, and toileting.

Are Alzheimer’s and Dementia the Same?

Alzheimer’s falls under the umbrella term dementia, which describes a group of symptoms related to a decline in mental abilities severe enough to impact daily functioning. The terms are sometimes used interchangeably, but there are some important distinctions between the two:

• Dementia is a general term for cognitive decline, while Alzheimer's is a specific disease and the most common cause of dementia.
• People with Alzheimer's will develop dementia over time, but not all people with dementia have Alzheimer's.
• Alzheimer's has defining brain changes like amyloid plaques and tau tangles. Some types of dementia, like vascular dementia, do not have these brain abnormalities.
• Medications used to treat Alzheimer's, like cholinesterase inhibitors, target specific brain changes and are not used for other non-Alzheimer's dementias.

While Alzheimer's disease is responsible for 60–80% of dementia cases, there are other causes of dementia as well, like vascular dementia, Lewy body dementia, frontotemporal dementia, and Parkinson's disease dementia.

Since there is currently no cure, Alzheimer’s disease treatments focus on managing symptoms and slowing progression. Some patients have turned to cannabis as a supplementary approach to manage symptoms and potentially slow progression. Research has shown that certain cannabis compounds have neuroprotective properties that could benefit people with Alzheimer’s disease. 

For example, THC and CBD have anti-inflammatory properties that reduce inflammation in the brain, which is believed to contribute to Alzheimer’s. Delta 8 THC and CBN appear to reduce amyloid beta proteins and tau phosphorylation, which contribute to the progression of Alzheimer’s disease. 

Intrigued? Let’s dive into the science behind the neuroprotective effects of cannabis compounds and see why microdosing cannabis with our edibles is probably the best thing you can do for your brain.

We’re going to be talking a lot about the main cannabis compound, Delta-9-tetrahydrocannabinol, so here’s everything you need to know about Delta 9 THC. 

What Is Microdosing Cannabis?

Microdosing cannabis is the practice of consuming small amounts of compounds found in the cannabis plant. Microdosed products contain very low amounts of cannabinoids. There are many ways to consume cannabis, but these low-dose edibles offer the easiest, safest, and healthiest method of consuming it every day while still feeling productive and functional.

With our low-dose edibles, you can:

• Avoid the carcinogens and lung damage associated with smoking.
• Get precise doses of Delta 9 THC, cannabidiol (CBD), and other cannabinoids.
• Get a slow release of beneficial compounds into your system, which gives you control over the exact amount of THC you’re taking (unlike other unreliable consumption methods).
• Enjoy natural flavors infused with real fruit.
• Avoid harmful ingredients, toxins, heavy metals, and pesticides that ruin the flavor and potency of your edibles.

All our cannabis edibles have been carefully crafted and tested in a third-party lab to ensure quality and safety. Our THC gummies contain high-quality ingredients and top-notch flavors that will turn your daily practice of microdosing into a delicious snack.

Check out our guide to the best THC microdosing products, where you can learn everything about our hemp-derived edibles. You’ll also read why we’re head over heels for our Euphoria strawberry gummies. They’re not just irresistible to your tongue. With low-dose THC and CBD (only 10 milligrams of each per gummy), these chews offer protection for your brain cells against dementia-related damage and deterioration. 

Before we delve into the potential of cannabis to help treat Alzheimer’s disease, let's briefly explain the function of our endocannabinoid system (ECS) so you’ll understand better how our brains use cannabinoids.

What is the Connection Between Alzheimer’s and the ECS?

The endocannabinoid system is a part of the central nervous system that helps regulate many important functions like sleep, pain, appetite, and cognitive processing. It is composed of cannabinoid receptors (CB1 and CB2 receptors) and endogenous cannabinoids produced naturally by our bodies. 

The ECS helps maintain homeostasis and health by binding endocannabinoids to these receptors throughout the brain and body. They act similarly to the cannabinoids THC and CBD from cannabis.

THC binds to both cannabinoid receptors, stimulating the ECS and neurotransmitter release in the brain. This disrupts communication between neurons and produces the intoxicating yet therapeutic effects of Delta 9 THC. 

You may ask why the endocannabinoid system is so important in the treatment of Alzheimer’s? Here’s why: 

Several findings indicate that the activation of both CB1 and CB2 receptors by natural or synthetic agonists, at non-psychoactive doses, have beneficial effects in Alzheimer experimental models by reducing the harmful β-amyloid peptide action and tau phosphorylation, as well as by promoting the brain’s intrinsic repair mechanisms. Moreover, endocannabinoid signaling has been demonstrated to modulate numerous concomitant pathological processes, including neuroinflammation, excitotoxicity, mitochondrial dysfunction, and oxidative stress. (Aso and Ferrer, emphasis ours)

The ECS has a modulatory role in Alzheimer's. As the disease progresses, deteriorating endocannabinoid function contributes to worsening symptoms. In Alzheimer’s, CB1 receptor density drops throughout the brain, reducing endogenous cannabinoid signaling. This impaired ECS function correlates with cognitive deterioration.

Disrupted ECS signaling contributes to many Alzheimer's symptoms. The buildup of amyloid beta and hyperphosphorylated tau proteins disturbs the function of the endocannabinoid system. Conditions like inflammation, oxidative stress, mitochondrial dysfunction, and apoptosis involved in Alzheimer's neurodegeneration also disrupt ECS signaling and endocannabinoid production.

As you can see, Alzheimer’s negatively impacts our endocannabinoid system in many ways. Cannabis compounds like THC and CBD help us restore balance and healthy function of the ECS and counteract many Alzheimer's-related changes. 

The interaction between THC and CB1 receptors particularly produces extraordinary neuroprotective properties that may help combat the progression of neurodegenerative diseases like Alzheimer’s disease. 

How Can Cannabis Help Alzheimer’s?

A growing body of clinical research suggests cannabis may have the potential to address both the symptoms and progression of Alzheimer’s disease. 

Cannabis Has the Potential to Alleviate Alzheimer’s Symptoms

THC and CBD may help relieve several of the hard-hitting symptoms of Alzheimer’s, including: 

• Anxiety and depression
• Insomnia
• Agitation and aggression
• Wasting (appetite loss)

THC and CBD for Anxiety and Depression

Alzheimer's patients often experience anxiety and depression as the disease progresses. At low doses, THC has demonstrated relaxing, anti-anxiety effects without psychoactivity, whereas higher doses may actually amplify anxiety. 

According to researchers at the University of Washington, CBD seems to decrease anxiety at any dose. 

THC appears to decrease anxiety at lower doses and increase anxiety at higher doses...

A low dose of THC (7.5 mg) reduced the duration of negative emotional responses to the task and posttask appraisals of how threatening and challenging the stressor was. In contrast, a higher dose of THC (12.5 mg) produced small but significant increases in anxiety, negative mood and subjective distress at baseline before and during the psychosocial stress task.

THC and CBD work by increasing serotonin levels and interacting with dopamine receptors to improve mood and reduce anxiety. That’s why we pair these two powerful cannabinoids in our Relax Plus gummies. 

The 25 milligrams of CBD is relaxing enough on their own. The “plus” is a tiny kick of THC (5 mg per gummy) to provide additional chill effects. The low dose THC amplifies CBD's calming properties, allowing distressing mood symptoms to melt away.

Sleep Better with Low Doses of Cannabis

Sleep disturbances are another symptom of Alzheimer's. Evidence indicates THC and CBD can improve sleep quality by interacting with the endocannabinoid system involved in regulating sleep-wake cycles. 

Alzheimer's patients often experience disrupted sleep cycles with frequent nighttime awakenings and decreased time spent in restorative deep sleep. According to research, THC helps us increase the time we spend in deep sleep (non-rapid eye movement sleep), shortening the time we spend dreaming in rapid eye movement (REM) sleep. 

THC may also increase sleep latency (the time you need to fall asleep) while increasing non-REM sleep. Deep non-REM sleep is thought to play an important role in clearing waste like amyloid beta from the brain. By spending more time in deep sleep, THC may aid this brain clearance function that can become impaired in Alzheimer's.

Also, decreased REM sleep means patients may experience fewer vivid dreams/nightmares which can further disrupt sleep. Less time in REM may also mean reduced agitation, a common symptom of Alzheimer's.

If you’re struggling with sleep, our sleep gummies may fix your problem and banish insomnia for good. The combination of CBD and THC in our Sleep Plus edibles enhanced with melatonin is our favorite cannabis product because it promotes deeper, more restorative sleep. 

With quality sleep critical for brain health, these gummies harness the power of key cannabinoids to combat insomnia and enhance overnight brain restoration.

Cannabis Alleviates Agitation and Aggression in Alzheimer’s Patients

Aggressive outbursts are a common behavioral symptom of Alzheimer's. As the brain deteriorates, patients often become increasingly irritated, restless, and prone to angry or violent outbursts. Dementia researchers with the Alzheimer Society Research Program have found that cannabis helps manage behavioral symptoms of dementia, like agitation and aggression.

According to the Alzheimer’s Society of Canada, the existing medication that can treat these Alzheimer’s symptoms often comes with harmful side effects and can “sometimes lead to stroke, or even death.”

Cannabinoids, on the other hand, interact with the body differently, which means they could be safer and more effective overall for someone experiencing agitation. Some of their effects are even thought to help reduce brain cell death.

In multiple studies, low doses of THC decreased irritability, resistiveness to care, shouting, physical aggression like hitting and pushing, and emotional distress. Researchers believe this calming effect of THC is due to its ability to interact with the brain's endocannabinoid system and serotonergic receptors involved in regulating mood and behavior. 

CBD and THC may increase serotonergic signaling by increasing available tryptophan, an essential amino acid that serves as a precursor for serotonin and other metabolites. As decreased serotonin production is implicated in the emergence of mood and behavioral disorders, reducing tryptophan degradation that is associated with several inflammatory diseases, such as AD, could be an effective therapy. (Outen, et. al.)

With aggressive outbursts taking a major toll on caregivers and patients' quality of life, THC's ability to calm Alzheimer's-related agitation is extremely promising. 

THC and CBD for Appetite Loss and Wasting

As Alzheimer's disease advances, patients progressively lose interest in food and often experience dramatic weight loss and muscle wasting. This appetite decline and nutritional deterioration are driven by Alzheimer's-related damage to brain regions that regulate hunger cues and digestion. Patients simply forget to eat or lose the drive to eat.

Fortunately, THC is known to stimulate appetite that may help counteract wasting. Delta 9 jumpstarts appetite by interacting with CB1 receptors in the ECS involved in regulating hunger signals. This triggers hunger signals and kickstarts digestive processes. 

One clinical trial found “significant alterations of the appetite hormones ghrelin, [peptide YY] and leptin in blood” after Delta 9 consumption. THC also interacts with the hypothalamus, an area of our brain that controls hunger and satiety, causing an increase in appetite. 

THC may also make you hungry by improving the sensory sensations of eating and making food appear more appealing. A double-blind, placebo-controlled trial examined whether THC can improve taste and smell perception as well as appetite, caloric intake, and quality of life for cancer patients. Patients treated with THC reported improved and enhanced chemosensory perception and said that the food ‘tasted better’.

Meanwhile, CBD appears to regulate appetite through different mechanisms. It modulates hormone levels and signals involved in hunger and satiety. CBD also reduces nausea and vomiting, which are additional barriers to adequate nutrition in Alzheimer's.

Introducing THC and CBD early on could help prevent the wasting process from taking hold in the first place.

Neuroprotective Potential of THC, CBD, CBN

In addition to managing symptoms, emerging research indicates certain cannabinoids may also slow the progression of Alzheimer’s by reducing underlying brain pathology. Delta 9 THC, CBD, CBN, and Delta 8 THC have all demonstrated neuroprotective properties that could defend brain cells against further damage from Alzheimer’s.

Delta 9 THC’s Neuroprotection Against Dementia

Delta 9 THC appears to reduce amyloid beta production and tau phosphorylation. The accumulation of these toxic proteins in the brain is heavily implicated in the development of Alzheimer’s disease. 

The antioxidant and potent anti-inflammatory properties counteract the harmful effects of oxidative stress and neuroinflammation, protecting neurons against Alzheimer’s and slowing neurodegeneration over time. 

…THC was effective at lowering both total GSK-3β levels and phosphorylated GSK-3β in a dose-dependent manner at low concentrations... low doses of THC can enhance mitochondria function... These sets of data strongly suggest that THC could be a potential therapeutic treatment option for Alzheimer's disease through multiple functions and pathways. (Cao, et. al.)

GSK-3β is an enzyme involved in tau phosphorylation. Excess GSK-3β contributes to tau tangles in Alzheimer's, which is, as we mentioned before, a segway into Alzheimer’s. At low, non-toxic amounts, THC was able to reduce the levels of GSK-3β.

Low THC also improved mitochondrial function, which is often impaired in Alzheimer's and other types of dementia. These findings suggest that, at low doses, Delta 9 THC could be a potential therapeutic option for dementia and Alzheimer’s disease

A 2019 study found that THC might actually be more effective in boosting memory and cognition in combination with CBD than in isolation.

Two in-vivo studies using CBD and THC at the same time showed that the CBD+THC treatment was effective on the memory of AβPP/PS1 transgenic mice and the CBD+THC was more effective than CBD alone or THC alone treatments.

Many of our edibles contain powerful combinations of THC and CBD. These are referred to as the entourage effect, a proposed theory in which cannabinoids have greater therapeutic and medicinal benefits when combined. THC amplifies the effects of CBD, and vice versa. Beautiful, isn’t it?

Even more beautiful are our full spectrum, entourage effect-approved d cannabis products. They combine the powerful effects of THC and CBD, making them an ideal way to elevate your brain health and battle Alzheimer’s. 

Order our full spectrum CBD gummies now.

CBD Reduces Harmful Oxidative Stress and Inflammation

Similarly to THC, CBD has the potential to clear abnormal protein deposits and block tau aggregation in the brain. As a powerful antioxidant, CBD also neutralizes free radicals and reduces inflammation-provoking cytokines.

The 2019 study that discovered the beneficial synergy of THC and CBD on cognition and memory demonstrated several ways that CBD exerts its neuroprotective properties on Alzheimer’s disease.

…studies using CBD were performed on PC12 neuronal cells. The results showed that CBD activated the Peroxisome Proliferator-Activated Receptor-γ(P-PARγ) through the Wnt/β-catenin pathway. As a result, it protected PC12 cells from Aβ neurotoxicity and oxidation stress, increased cell survival, reduced ROS production, reduced lipid peroxidation, inhibited the hyperphosphirylation of tau protein, and inhibited AChE. (Kim, et. al.)

What all this means is that CBD has demonstrated the ability to defend neuron cells against various forms of damage related to Alzheimer's pathology. It displayed antioxidant, anti-inflammatory, and neuroprotective effects in these preliminary lab studies. 

More research is still needed to confirm these findings, but CBD shows promise as a potential supplemental treatment for Alzheimer’s disease. 

Shop our pure hemp-derived CBD edibles to experience the lofty benefits of cannabidiol and improve your brain health.

Cannabinol Improves Cognitive Function

Cannabinol, or CBN, is a cannabinoid found in trace amounts in cannabis. Research indicates CBN has neuroprotective properties that could make it useful for managing age-related cognitive decline.

Here are some extraordinary effects of CBN that could benefit people with Alzheimer’s:

• CBN has been shown to reduce inflammation, oxidative stress, and amyloid beta proteins in the brain. Clearing these Alzheimer's-associated pathologies may protect neurons and slow further deterioration.
• CBN has mighty anxiolytic properties, making it useful in alleviating symptoms of anxiety in people living with Alzheimer’s. 
• CBN also activates stem cells in the brain, which are involved in repairing neurological damage. This could stimulate brain regeneration to counteract disease progression. Just like other cannabinoids, CBN is involved in neurogenesis, the process of creating new neurons in the brain.
• In mouse models, CBN was able to improve memory and learning deficits caused by neurotoxicity or age-related cognitive impairment.

While human data is still lacking, these preliminary findings suggest CBN has the potential to slow cognitive decline in dementia and Alzheimer's. Used in microdoses, CBN may provide cognitive benefits and brain cell protection without causing significant intoxication.

What a great excuse to order our CBN gummies and enjoy the therapeutic synergy of CBN and its close cousin CBD. (Just to be clear, cannabinol and cannabidiol are not the same cannabis compound.)

How Effective Is Delta 8 Against Alzheimer’s?

Speaking of cousins, meet Delta-8-tetrahydrocannabinol, Delta 9’s “younger brother.” Delta 8 and Delta 9 share a lot of benefits, but unlike Delta 9, Delta 8 THC is less intoxicating and causes little to no psychoactivity even when consumed in higher amounts. 

And just like Delta 9, Delta 8 is great at reducing neuroinflammation and amyloid proteins in dementia patients.

Researchers looked at the effects of Delta 8 THC on neuron-like cells treated with amyloid beta (Aβ) to model Alzheimer's disease. They found that Delta 8 restored the viability of cells damaged by it and protected the cells from dying. Delta 8 also normalized the expression of genes involved in proper protein folding and degradation that were disrupted by amyloid beta.

These powerful neuroprotective effects in this Alzheimer's model suggest that Delta 8 is a promising supplemental therapeutic agent for managing Alzheimer's disease. Microdoses of Delta 8 could potentially slow progression and boost cognition with improved tolerability. 

Speaking of microdoses, our low-dose Delta 8 gummies are expertly crafted to give you all the benefits without the psychoactive feelings. With just 12.5 mg of hemp-derived Delta 8 per gummy, you get a smooth, mellow buzz that's perfect for staying active and engaged. With potential neuroprotective abilities, these gummies let you harness their therapeutic promise in a convenient chew. 

Cannabis Dosing Recommendations for Alzheimer’s

As a potential aid for Alzheimer's, cannabis might hold the key to treating this and many other neurodegenerative disorders. We take the saying “less is more” quite literally, so we make sure our edibles—both gummies and THC drinks—are packed with some serious microdose action. 

For Alzheimer’s patients, we recommend low doses. Anywhere between 2 and 10 milligrams of Delta 9 will do the trick. These amounts are superheroes in the fight against Alzheimer's disease, far better than higher doses. Here’s why:

• Microdosing allows you to find the balance between getting comfortably buzzed and maintaining mental clarity, making it an ideal approach for Alzheimer's patients seeking relief without compromising their cognitive function.
• Microdosing also minimizes the risk of cognitive impairment that comes with higher doses. 
• This is also true for your mental health. Remember how low doses decrease anxiety while higher doses of THC amplify anxiety and depression? Microdosing edibles is and always will be an ally to your mental health. 
• Lower doses of cannabis compounds can contribute to a more stable and positive mood, improving the overall emotional well-being of Alzheimer's patients.
• By taking smaller amounts of THC and other potentially psychoactive compounds, you avoid the strong psychotropic effects of higher doses. 
• Because of the way they are digested, edibles take longer to kick in. But once they do, their effects can last much longer than when you smoke or vape. This is also true for THC drinks, like our very own Buzz THC drops. Unlike smoked cannabis, whose effects vaporize after an hour or so (two hours tops), the effects of drinking THC can last up to six hours.

Have we introduced our Bliss gummies yet? Packed with balanced amounts of THC and CBD (only 5 mg each), these honeydew melon chews activate your gray cells and help you cope with the stress that conditions like Alzheimer’s and dementia bring. These gummies aren't about getting high; they're about finding relief and supporting you on your journey to wellness. 

What Are the Best Cannabis Edibles for Alzheimer’s?

Get ready to dive into a world of awesome edibles. The good news is that dementia won't be joining the party. 

We've whipped up some seriously cool gummies that are 100% vegan, made from top-notch hemp, and legal at the federal level in the US. Take a look at our list of the best microdosing edibles that can tackle your dementia symptoms and battle Alzheimer’s.

• Delta 8 THC gummies are the best way to elevate your mood and brain defenses in a natural way. These gummies with 12.5 mg of Delta 8 THC are like the gentlest lift-me-up wrapped in a passion fruit and wild peach flavor explosion. Trust us, microdosing weed has never been this delightful.
• If you need to activate your gray cells, try our Bliss Delta 9 gummies. These fruity wonders pack in both THC and CBD (5 mg each) to give your gray cells a high-five while helping you keep stress at bay. 
• Our Relax Plus gummies are perfect if you need some serious relaxation that tastes like watermelon. These babies team up balanced CBD and THC content for that ultimate chill pill experience that will clear your mind from stress and confusion and light up the way to improved brain health.
• Struggling with sleep? Our collection of melatonin gummies is here to save the night. Order our Sleep Plus gummies with 25 mg of CBD, 2 mg of THC, and a dash of melatonin. Bedtime just got a tasty upgrade with the most soothing lavender flavor.

It's time to treat yourself (or your loved ones) to some seriously chill moments with nama. Order your favorite flavors and products today. 

Resources

Aso, E., & Ferrer, I. (2014, March 5). Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic. PubMed Central (PMC). https://doi.org/10.3389/fphar.2014.00037

Stoner SA. Effects of Marijuana on Mental Health: Anxiety Disorders. Alcohol & Drug Abuse Institute, University of Washington, June 2017. URL: http://adai.uw.edu/pubs/pdf/2017mjanxiety.pdf

Cannabis, Cannabinoids, and Sleep: a Review of the Literature - PubMed. (2017, April 1). PubMed. https://doi.org/10.1007/s11920-017-0775-9

The Alzheimer Society Research Program. (n.d.). Alzheimer Society of Canada. http://alzheimer.ca/en/research/alzheimer-society-research-program

Clearing the air about cannabis and dementia. (n.d.). Alzheimer Society of Canada. http://alzheimer.ca/en/whats-happening/news/clearing-air-about-cannabis-dementia

Cannabinoids for Agitation in Alzheimer’s Disease. (2021, January 27). Cannabinoids for Agitation in Alzheimer’s Disease - ScienceDirect. https://doi.org/10.1016/j.jagp.2021.01.015

Riggs, P. K., Vaida, F., Rossi, S. S., Sorkin, L. S., Gouaux, B., Grant, I., & Ellis, R. J. (2011, November 7). A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men. PubMed Central (PMC). https://doi.org/10.1016/j.brainres.2011.11.001

Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. (2020, January 6). ScienceDirect. https://doi.org/10.1093/annonc/mdq727

The potential therapeutic effects of THC on Alzheimer’s disease - PubMed. (2014, January 1). PubMed. https://doi.org/10.3233/JAD-140093

Kim, S. H., Yang, J. W., Kim, K. H., Kim, J. U., & Yook, T. H. (2019, December 31). A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC. PubMed Central (PMC). https://doi.org/10.3831/KPI.2019.22.030

Kim, S. H., Yang, J. W., Kim, K. H., Kim, J. U., & Yook, T. H. (2019, December 31). A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC. PubMed Central (PMC). https://doi.org/10.3831/KPI.2019.22.030

Gugliandolo, A., Blando, S., Salamone, S., Caprioglio, D., Pollastro, F., Mazzon, E., & Chiricosta, L. (2023, April 2). Δ8-THC Protects against Amyloid Beta Toxicity Modulating ER Stress In Vitro: A Transcriptomic Analysis. PubMed Central (PMC). https://doi.org/10.3390/ijms24076598

nama CBD FDA & Legal Disclaimer

Our products are not intended to diagnose, treat, cure, or prevent any disease. They are not a replacement for prescription medications and have not been evaluated by the Food and Drug Administration (FDA).

The information provided on this website does not, and is not intended to, constitute legal advice or any statement of the status of any laws. Any information, content, and materials available on this site are for general informational purposes only, and are not intended to be relied upon for any purpose.

Readers of this website should contact their attorney to obtain advice with respect to any particular legal matter, including decisions on what products are, or are not, legal to sell, possess, or consume. No reader, user, or browser of this site should act or refrain from acting on the basis of the information on this site without first seeking legal advice from their own counsel in the relevant jurisdiction.